Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

News > All

Total search results: 9859 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 53 54 55 ... 97 98 99  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Maverix Biomics, Inc.. (11/13/13). "Press Release: Maverix Biomics Forms Strategic Co-marketing Alliance with Qiagen". Phoenix, AZ. 2013-11-13
Merck Serono. (11/13/13). "Press Release: Merck Enters into Further Global Co-development and Commercialization Agreement for PARP Inhibitor with Chinese R&D Company BeiGene". Darmstadt. 2013-11-13
Scienion AG. (11/13/13). "Press Release: Scienion Introduces Line Dispenser for Membrane Materials with Full Drop Formation Control at Medica 2013". Dortmund & Berlin. 2013-11-13
Bruker Corporation. (11/13/13). "Press Release: Application Note for Analysis of Carbendazim in Orange Juice and Wine Using Bruker’s EVOQ". 2013-11-13
Max-Planck-Institut für marine Mikrobiologie. (11/13/13). "Press Release: Nicole Dubilier Appointed Director at the Max Planck Institute in Bremen". 2013-11-13
IntercontinentalExchange, Inc.. (11/13/13). "Press Release: IntercontinentalExchange Completes Acquisition of NYSE Euronext. Creates the Leading Network of Global Derivatives and Equity Exchanges". Atlanta, GA & New York, NY. 2013-11-13
MeVis Medical Solutions AG. (11/12/13). "Press Release: Voting Rights. Publication according to Article 26 Section 1 WpHG [Shareholding of Dr Carl JG Evertsz Fallen to 14.9995%]". 2013-11-12
Evotec AG. (11/12/13). "Press Release: Evotec AG Reports First Nine Months 2013 Results". Hamburg. 2013-11-12
Scil Proteins Production GmbH. (11/12/13). "Press Release: Scil Proteins Production to Join Wacker, Creating Leading Microbial-based Biopharmaceutical Manufacturer". Halle. 2013-11-12
Affimed Therapeutics AG. (11/12/13). "Press Release: Affimed Therapeutics Appoints Dr. Jens-Peter Marschner as Chief Medical Officer". Heidelberg. 2013-11-12
MeVis Medical Solutions AG. (11/11/13). "Press Release: MeVis’ Leap in Sales and Profits in the Third Quarter". Bremen. 2013-11-11
ApoCell Inc.. (11/11/13). "Press Release: ApoCell, Inc. Expands into Europe, Establishes Laboratory in Germany and Partners with the Fraunhofer Institute for Cell Therapy and Immunology". Houston, TX. 2013-11-11
MacroGenics, Inc.. (11/11/13). "Press Release: MacroGenics DART Therapeutic Selected by Boehringer Ingelheim as a Bi-specific Pre-clinical Development Candidate". Rockville, MD. 2013-11-11
Novartis AG. (11/11/13). "Press Release: Novartis Announces Divestiture of Its Blood Transfusion Diagnostics Unit to Grifols. Spain-based Grifols to Acquire Novartis Blood Transfusion Diagnostics Unit for USD 1.675 Billion". Basel. 2013-11-11
Evotec AG. (11/8/13). "Press Release: Evotec Announces TargetAD Collaboration with Johnson & Johnson Innovation to Identify and Develop Novel Alzheimer’s Disease Therapies". Hamburg. 2013-11-08
Medigene AG. (11/8/13). "Press Release: Medigene Reports Financial Results for the First Nine Months of 2013". Martinsried. 2013-11-08
Activaero GmbH. (11/8/13). "Press Release: Activaero Appoints Dr. Ulrich Dauer as Chief Strategy Officer". Gmünden / Wohra. 2013-11-08
4SC AG. (11/7/13). "Press Release: 4SC Announces Improved Financial Results for the Third Quarter and First Nine Months of 2013". Planegg-Martinsried. 2013-11-07
BRAIN AG. (11/7/13). "Press Release: Research Alliance for the Microbial Production and Application of Biopolymers". Zwingenberg et al.. 2013-11-07
MorphoSys AG. (11/7/13). "Press Release: MorphoSys AG Reports Results for the First Nine Months of 2013". 2013-11-07
Wilex AG. (11/7/13). "Press Release: Wilex Regains US Rights for Rencarex from Prometheus". Munich. 2013-11-07
Paion AG. (11/6/13). "Press Release: Interim Report by Management for the Second Half of the Year 2013 according to § 37X WPHG for the Period from 1 January to 30 September 2013". Aachen. 2013-11-06
Epigenomics AG. (11/6/13). "Press Release: Epigenomics AG Announces 2013 Third Quarter and Nine Month Financial Results and Reports Operational Highlights". Berlin. 2013-11-06
Biocartis S.A.. (11/5/13). "Press Release: Biocartis Poised for 2014 Commercial Launch with EUR 30 Million Series E Equity Fundraising". Mechelen & Lausanne. 2013-11-05
ADC Therapeutics S.a.r.l.. (11/5/13). "Press Release: ADC Therapeutics Licenses Proprietary Antibodies from Five Prime Therapeutics, Adds an Additional Proprietary ADC Development Program in Oncology". Lausanne & South San Francisco, CA. 2013-11-05
Formycon AG. (11/5/13). "Press Release: Formycon AG beschließt Kapitalerhöhung mit Bezugsrecht". München. 2013-11-05
Analytik Jena AG. (11/5/13). "Press Release: Analytik Jena Adjusts Results Expectations [Ad-hoc notification]". Jena. 2013-11-05
Valneva S.E.. (11/5/13). "Press Release: Valneva Records Highest Ixiaro/Jespect Sales in Q3 2013, Confirms Full Year Outlook, and Provides R&D Update for Pseudomonas Vaccine Candidate". Lyon. 2013-11-05
Formycon AG. (11/4/13). "Press Release: Formycon AG Today Has Announced the Appointment of Gerhard Schaefer and Simon Sturge to Formycon’s Advisory Board". Munich. 2013-11-04
Utrecht University. (11/4/13). "Press Release: Alexander Makarov Appointed as Professor of High Resolution Mass Spectrometry. Strengthening of Collaboration with Thermo Fisher Scientific". 2013-11-04
Kadimastem Ltd.. (11/4/13). "Press Release: Merck Serono and Kadimastem Sign Memorandum of Understanding (MOU) on Drug Screening and Discovery for Neurodegenerative Diseases". Nes Ziona & Darmstadt. 2013-11-04
Actelion Ltd.. (11/4/13). "Press Release: Actelion Announces U.S. Commercial Availability of Opsumit (macitentan) as of November 4". South San Francisco, CA. 2013-11-04
CureVac GmbH. (11/4/13). "Press Release: CureVac Collaborates with the Cancer Research Institute and Ludwig Cancer Research to Enalbe Clinical Testing of Novel Immunotherapy Treatment Options for Cancer". Tübingen & New York, NY. 2013-11-04
4SC AG. (11/4/13). "Press Release: AiCuris, 4SC Discovery and Crelux Announce Drug Discovery Collaboration". Planegg-Martinsried & Wuppertal. 2013-11-04
Canbex Therapeutics Ltd.. (11/4/13). "Press Release: Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R as a Potential Treatment for Spasticity in Multiple Sclerosis". London. 2013-11-04
Hookipa Biotech AG. (11/4/13). "Press Release: Hookipa Biotech Closes €20 Million ($27.5 Million) in Series B Financing. Funds to Be Used to Progress Viral Vaccine Pipeline and to Explore Applications in Cancer Immunotherapy". Vienna. 2013-11-04
Roche. (11/4/13). "Press Release: Roche and Polyphor Join Efforts to Combat Multi-drug-resistant Bacterial Infections". Basel. 2013-11-04
Bruker Corporation. (11/1/13). "Press Release: Bruker Corporation Reports Third Quarter 2013 Financial Results". Billerica, MA. 2013-11-01
Biognosys AG. (11/1/13). "Press Release: New Release of iRT Kit". 2013-11-01
Anton Paar GmbH. (11/13). "Press Release: Anton Paar GmbH Acquires CSM Instruments SA". 2013-11-01
BASF SE. (10/31/13). "Press Release: BASF Successfully Completes Verenium Tender Offer. Cash Tender Offer of US$4.00 per Share Successful – Approximately 71% of Verenum’s Shares Tendered". Ludwigshafen. 2013-10-31
Merck Serono. (10/31/13). "Press Release: Merck Serono Announces Five-year Strategic Partnership with the Lead Disovery Center". Darmstadt. 2013-10-31
SCiLS GmbH. (10/30/13). "Press Release: Carl Evertsz Appointed as Chairman of the SCiLS Advisory Board". Bremen. 2013-10-30
Paion AG. (10/30/13). "Press Release: Paion Grants License to R-Pharm for Remimazolam". Aachen. 2013-10-30
Curetis AG. (10/30/13). "Press Release: Curetis Receives Clearance for Unyvero System and Pneumonia Application in Russia and Serbia". Holzgerlingen. 2013-10-30
Stratec Biomedical AG. (10/30/13). "Press Release: Stratec Reports on First Nine Months of 2013". Birkenfeld. 2013-10-30
Genedata AG. (10/30/13). "Press Release: Sanofi Adopts Genedata Biologics for Integrated Biopharma R&D Process Support". Basel. 2013-10-30
Bicoll GmbH. (10/29/13). "Press Release: Bicoll Receives Payment as Member of the €11.5 Million EU Funded EpimiRNA Project to Develop Novel Epilepsy Therapeutics". 2013-10-29
ETH Zürich. (10/29/13). "Press Release: An Artificial Enzyme that Promotes 700 Reactions per Second". 2013-10-29
Qiagen GmbH. (10/29/13). "Press Release: Qiagen Reports Third Quarter 2013 Results". Venlo. 2013-10-29
Tecan Group Ltd.. (10/29/13). "Press Release: Tecan’s AC Extraction Plate Provides a Unique Sample Preparation Tool for LC-MS". Männedorf. 2013-10-29
Evotec AG. (10/28/13). "Press Release: Evotec Achieves First Milestones in Multi-target Deal with UCB". Hamburg. 2013-10-28
Definiens AG. (10/28/13). "Press Release: Definiens Expands Management Team to Develop the Clinical Market". 2013-10-28
Epigenomics AG. (10/28/13). "Press Release: Epigenomics and BioChain Enter into Broad Strategic Collaboration in China and Investment into Epigenomics". Berlin, Newark, CA & Beijing. 2013-10-28
Paion AG. (10/28/13). "Press Release: Paion AG Grants License to Hana Pharm for Remimazolam in South Korea". Aachen. 2013-10-28
Sygnis AG. (10/28/13). "Press Release: Sygnis AG Successfully Completes Rights Offering and Private Placement". Heidelberg. 2013-10-28
Biognosys AG. (10/25/13). "Press Release: SWATH Enabling Software Spectronaut Referenced in Recent Publications". 2013-10-25
Biotest AG. (10/24/13). "Press Release: Biotest AG Successfully Placed a Schuldschein of EUR 210 m". Dreieich. 2013-10-24
Franz Haniel & Cie. GmbH. (10/24/13). "Press Release: Haniel Sells Its Entire Stake to McKesson Corporation. EUR 23.00 per Share, Takeover Premium of 39%". 2013-10-24
Basilea Pharmaceutica Ltd.. (10/23/13). "Press Release: Basilea’s Antibiotic Ceftobiprole Obtains Regulatory Approval in Europe for Pneumonia". Basel. 2013-10-23
Apeptico Forschung und Entwicklung GmbH. (10/23/13). "Press Release: Apeptico Announces a Licensing Agreement for Pepbase with Chem Tech Research Incorporation (C-TRI)". Vienna. 2013-10-23
Mologen AG. (10/23/13). "Press Release: Approval for Phase I Study with MGN1703 in the U.S. Obtained". 2013-10-23
GlycoUniverse GmbH & Co. KG. (10/23/13). "Press Release: Sugar Is Life – GlycoUniverse Successfully Launched at Biotechpark Berlin-Buch". Berlin. 2013-10-23
McKesson Corporation. (10/23/13). "Press Release: McKesson Announces Agreement to Purchase Celesio to Create Leading Global Healthcare Services Platform". San Francisco, CA & Stuttgart. 2013-10-23
Thermo Fisher Scientific Inc.. (10/23/13). "Press Release: University of Salzburg, Sandoz and Thermo Fisher Scientific Collaborate at New Biosimilar Characterization R&D Facility". Salzburg. 2013-10-23
Biobase GmbH. (10/23/13). "Press Release: Biobase Launches PharmacoGenomic Mutation Database (PGMD) – a Knowldege-base Containing Genetic Variants that Affect Drug Response". Beverly, MA. 2013-10-23
Siemens AG. (10/23/13). "Press Release: New Siemens HIV Combo Assay Provides Quick and Reliable Results". Tarrytown, NY. 2013-10-23
F-Star Biotechnologische Forschungs- und Entwicklungsges. m.b.H.. (10/23/13). "Press Release: F-Star Announces Formation of New Asset-centric Vehicle, F-Star Alpha Ltd, with €9.4m Series A Investment. F-Star Alpha to License Oncology and Immune-oncology 2013-10-23
Peak Scientific Instruments Ltd.. (10/22/13). "Press Release: Peak Scientific Sign Formal OEM Agreement with Bruker’s Chemical and Applied Markets Division". 2013-10-22
Tecan Group Ltd.. (10/22/13). "Press Release: Enhancing Clinical Diagnostics with Tecan’s Cavro OmniRobot". Männedorf. 2013-10-22
Beactica AB. (10/22/13). "Press Release: Beactica Expands Its Drug Discovery Collaboration with Boehringer Ingelheim". Uppsala. 2013-10-22
Biocartis S.A.. (10/22/13). "Press Release: Biocartis Presents the Successful Use of Idylla for the Detection of BRAF Mutation Status in Tumour Samples at the International AACR Congress in Boston". Mechelen & Lausanne. 2013-10-22
Curetis AG. (10/22/13). "Press Release: Curetis Presents First Data on Novel Unyvero i60 ITI Application for Implant and Tissue Infections". Holzgerlingen. 2013-10-22
Finox AG (Finox Biotech). (10/22/13). "Press Release: Finox Biotech Shareholders Agree Capital Increase". Burgdorf. 2013-10-22
MorphoSys AG. (10/22/13). "Press Release: MorphoSys Strenghtens Patent Position on anti-CD19 Cancer Program MOR208". 2013-10-22
Novartis AG. (10/22/13). "Press Release: Novartis Delivers Strong Sales Performance in Third Quarter Driven by Growth Products’ Momentum – Innovation Newsflow Reinforces Growth Prospects". Basel. 2013-10-22
Samsung BioLogics. (10/22/13). "Press Release: Samsung BioLogics Signs a Strategic Manufacturing Partnership with Roche". Seoul. 2013-10-22
Biofrontera AG. (10/21/13). "Press Release: Allergan Launches Ameluz in Spain". Leverkusen. 2013-10-21
Evonik Industries AG. (10/21/13). "Press Release: Evonik Opens a New Plant in Argentina for Catalysts Used in Biodiesel Production". Essen. 2013-10-21
Evotec AG. (10/21/13). "Press Release: Evotec Enters Integrated Alliance with AstraZeneca in Kidney Disease". Hamburg. 2013-10-21
Ganymed Pharmaceuticals AG. (10/21/13). "Press Release: Ganymed’s IMAB362 Receives Orphan Drug Designation from FDA and EMA for Pancreatic Cancer". Mainz. 2013-10-21
Qiagen N.V.. (10/21/13). "Press Release: Qiagen Announces Partnership with Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-resistant EGFR Mutations". Germantown, MD & Hilden. 2013-10-21
Sartorius AG. (10/21/13). "Press Release: Nine-Month Figures for 2013. Sartorius with Gains in Order Intake, Sales Revenue and Earnings". Göttingen. 2013-10-21
Sartorius AG. (10/21/13). "Press Release: Nine-Month Figures 2013. Sartorius Stedim Biotech on Track Towards Reaching Its 2013 Targets". 2013-10-21
University of Salzburg. (10/21/13). "Press Release: On the Test Bench. Protein-based Drugs". Salzburg. 2013-10-21
Biognosys AG. (10/18/13). "Press Release: US Patent Awarded to Biognosys". 2013-10-18
Mologen AG. (10/18/13). "Press Release: Clinical Study with MGN1404 in Malignant Melanoma Initiated. Phase I Trial to Evaluate Safety and Tolerability". 2013-10-18
Neovacs S.A.. (10/18/13). "Press Release: Miguel Sieler, former Chairman and CEO Bayer France, Named CEO of Neovacs". Paris. 2013-10-18
Actelion Ltd.. (10/18/13). "Press Release: Actelion Receives US FDA Approval for Opsumit (macitentan) for the Treatment of Pulmonary Arterial Hypertension". Allschwil. 2013-10-18
Actelion Ltd.. (10/17/13). "Press Release: Actelion on Track to Deliver Double Digit LC Core Earnings Growth". Allschwil. 2013-10-17
Biocartis S.A.. (10/17/13). "Press Release: Biocartis and Hospital del Mar Join Forces to Develop Diagnostic Colon Cancer Test". Lausanne, Mechelen & Barcelona. 2013-10-17
Biodesy, Inc.. (10/17/13). "Press Release: Biodesy Inc. Completes $15.0 Million Series A Financing and Appoints Greg Yap as Chief Executive Officer. Series A Investors include 5AM Ventures, Pfizer Venture Investments and Roche Venture". Burlingame, CA. 2013-10-17
LISAvienna. (10/17/13). "Press Release: Current Study on Life Sciences in Vienna. More than 35,000 Employees in Companies and Research Institutions". Vienna. 2013-10-17
BASF SE. (10/17/13). "Press Release: BASF Inaugurates New Facility for Plant Biotechnology Research in Ghent, Belgium. BASF Subsidiary CropDesign Moves into a New Building in Technologiepark". Ludwigshafen & Ghent. 2013-10-17
Roche. (10/17/13). "Press Release: Roche Posts Strong Sales Growth in the First Nine Months of 2013". Basel. 2013-10-17
Sygnature Discovery Ltd.. (10/17/13). "Press Release: Sygnature Discovery and Proteros Biostructures Establish Strategic Alliance". Nottingham & Munich. 2013-10-17
Certara. (10/17/13). "Press Release: Boehringer Ingelheim Selects Certara’s D360 as Its Global Drug Discovery Platform". St. Louis, MO. 2013-10-17
Firefly BioWorks. (10/16/13). "Press Release: Firefly BioWorks Announces Strategic Partnership with EMD Millipore". Cambridge, MA. 2013-10-16
Glycotope GmbH. (10/16/13). "Press Release: Glycotope Reported Promising First-in-Man Data of Novel Glycooptimized Monoclonal Anti-TA-MUC1 Antibody PankoMab-GEX". Berlin. 2013-10-16
High-Tech Gründerfonds Management GmbH. (10/16/13). "Press Release: Patient Monitoring at Cellular Level. High-Tech Gründerfonds und Bayern Kapital Lead Investment in Photonics Healthcare". Bonn, Landshut & Garching. 2013-10-16
next pagenext page 1 2 3 ... 53 54 55 ... 97 98 99  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top